Tema Oncology ETF
CANC
NASDAQ
| Weiss Ratings | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Reward Grade | U | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Valuation | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $26.47 | |||
| Company Info | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Tema Global Limited | |||
| Manager/Tenure (Years) | Troy Cates (1), Ryan Houlton (1), Yuri Khodjamirian (1), 3 others | |||
| Website | -- | |||
| Phone Number | -- | |||
| Fund Information | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Tema Oncology ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Growth | |||
| Inception Date | Aug 14, 2023 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.92% | |||
| Dividend | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.16% | |||
| Asset Allocation | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.31% | |||
| Stock | 99.69% | |||
| U.S. Stock | 69.83% | |||
| Non-U.S. Stock | 29.86% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.25% | |||
| 30-Day Total Return | 3.74% | |||
| 60-Day Total Return | 12.67% | |||
| 90-Day Total Return | 13.30% | |||
| Year to Date Total Return | 7.87% | |||
| 1-Year Total Return | -8.04% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| Price | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $26.47 | |||
| 1-Month Low Price | $24.38 | |||
| 1-Month High Price | $26.47 | |||
| 52-Week Low Price | $20.98 | |||
| 52-Week Low Price (Date) | Apr 08, 2025 | |||
| 52-Week High Price | $29.87 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| NAV | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $24.42 | |||
| 1-Month High NAV | $26.45 | |||
| 52-Week Low NAV | $20.96 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $29.85 | |||
| 52-Week High Price (Date) | Aug 26, 2024 | |||
| Beta / Standard Deviation | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | -- | |||
| Balance Sheet | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 71.60M | |||
| Operating Ratios | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.75% | |||
| Turnover Ratio | 95.00% | |||
| Performance | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 4.61% | |||
| Last Bear Market Total Return | -- | |||